Status:
COMPLETED
Cognitive and Balance Dual Task Training for People With Schizophrenia
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborating Sponsors:
Kaohsiung Medical University
Ministry of Science and Technology, Taiwan
Conditions:
Schizophrenia
Cognition
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
After developing and pilot testing the training program, including the CogBals software, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants and then randomly alloc...
Detailed Description
Background: Individuals with schizophrenia often experience premature aging and accelerated aging, which increases the challenge of care and recovery. Improvement on balance and implementation of prev...
Eligibility Criteria
Inclusion
- diagnosis of schizophrenia or schizoaffective disorder for more than 1 year by psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5)
- age 40-75 years old
- have stable psychiatric symptoms currently (main psychotropic medications have not been adjusted for two months
- being able to ambulate independently for more than 10 meters, without a walking device
- not have significant cognitive impairment (Montreal Cognitive Assessment Taiwan Version, MoCA≧20)
- can follow study protocol and sign the informed consent form
Exclusion
- currently in the psychiatric acute award
- currently alcohol or drug use disorder
- Pregnancy, head trauma and other neuromusculoskeletal injuries affect training safety and compliance
- intellectual disability
- Unconsciousness or confusion
- According to the subject's self-report, those with the following medical history, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, poor blood sugar control (i.e., renal dialysis treatment, diabetic neuropathy or retinopathy), no well-controlled hyperemia: systolic blood pressure\> 160 mmHg or diastolic blood pressure\> 110 mmHg
- Currently participating in other interventional study
Key Trial Info
Start Date :
May 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05341804
Start Date
May 10 2022
End Date
September 15 2023
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University
Kaohsiung City, Taiwan, 807